Biopharmaceutical Manufacturers To Be Given Support In Optimizing Cell Culture Media Filtration

The challenges of effective filtration of critical media are to be addressed in a new webinar delivered by Parker Bioscience Filtration.

Taking place on June 18, the webinar, Optimization of Cell Culture Media Filtration in Bioprocessing, will be led by David Heaney, market development manager at Parker Bioscience Filtration.

By taking part in the webinar, biopharmaceutical manufacturers can learn how to reduce the risk of process contamination and cell culture loss by choosing the right filtration trains to optimize their unit operations.

This webinar will focus on why cell culture media can be so problematic to filter and introduce case studies that examine bacterial retention properties of different filters in complex media. Webinar attendees will also gain an understanding of the properties of the media that will influence filter choice.

Selecting the right filter can ensure that processing complex solutions can remain consistent – even when batch to batch variation exists – maintaining bioreactor or culture vessel sterility during the critical upstream phase.

Presenter David Heaney will be joined by Katy Angus, research project manager at Parker Bioscience Filtration and Paul Hymus, product manager – filtration at Parker Bioscience Filtration.

Registration for the webinar is free.

David Heaney, market development manager at Parker Bioscience Filtration said: “If bacteria present in cell culture media, such as Mycoplasma, is not removed, this can result in costly incidents of process contamination and cell culture loss.

“However, we recognize that effective filtration of critical media can be a challenge, due to the complex nature of today’s cell culture medias, as well as batch to batch variation.

“This webinar will provide valuable insight into cell culture media filtration, using case studies that examine the bacterial retention properties of different filters in complex media.

“We will be sharing our expertise and extensive experience of working with biopharmaceutical manufacturers to help those working in bioprocessing operations to optimize their cell culture filtration systems.

“The webinar will provide valuable guidance for personnel including cell culture scientists and operations managers, plus those working in upstream processing development, upstream processing management and quality assurance.”

Parker Bioscience Filtration is part of Parker Hannifin, the world's leading diversified manufacturer of motion and control technologies and systems. It designs, supplies and delivers whole systems for both upstream and downstream pharmaceutical and biopharmaceutical manufacturing.

With sites in Birtley, UK and Oxnard, California, the company supports customers both locally and globally in improving process control, efficiency and supply chain security throughout their production and packaging processes.

Parker Bioscience Filtration provides integrated bioprocessing solutions that accelerate development times, and increase efficiency and safety to enable reproducible quality. Incorporating the expertise within SciLog^® and domnick hunter, the company combines filtration, single-use fluid-handling systems and sensors into automated single-use solutions.

The webinar, Optimization of Cell Culture Media Filtration in Bioprocessing, will take place on Thursday June 18, 2020 at 3pm London time / 10am New York time. To register and for more information visit: https://www.business-review-webinars.com/webinar/Pharma/Optimization_of_cell_culture_media_filtration_in_bioprocessing-TyLZjw8R

For more information, visit www.parker.com/bioscience

About Parker Hannifin
Parker Hannifin is a Fortune 250 global leader in motion and control technologies. For 100 years the company has engineered the success of its customers in a wide range of diversified industrial and aerospace markets. For more information, visit www.parker.com.